These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2397644)

  • 1. Correlation of class I antigen expression with immunogenicity.
    Almond PS; Baumgardner GL; Chen S; Cunningham TR; Payne WD; Matas AJ
    Curr Surg; 1990; 47(4):262-4. PubMed ID: 2397644
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of class I+, class II- hepatocytes.
    Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional characteristics of liver T-lymphocytes in the allogenic response to mutant MHC class I and II molecules].
    Chernysheva AD; Brondz BD; Anosova NG; Boĭko RZ; Aĭzenberg LV; Kazanskiĭ DB
    Mol Biol (Mosk); 1996; 30(3):721-8. PubMed ID: 8754021
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture.
    So SK; Wilkes LM; Platt JL; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):251-2. PubMed ID: 3274778
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of Ia-unrestricted primary anti-Qa-1 cytotoxic T lymphocyte responses by class II major histocompatibility complex-restricted cellular interactions.
    Huston DP; Tavana G
    J Immunol; 1987 May; 138(9):2753-9. PubMed ID: 3106487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC of cattle and sheep.
    Spooner RL; Teale AJ; Cullen P
    Prog Vet Microbiol Immunol; 1988; 4():88-107. PubMed ID: 3078870
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraepithelial lymphocytes: exploring the Third Way in immunology.
    Hayday A; Theodoridis E; Ramsburg E; Shires J
    Nat Immunol; 2001 Nov; 2(11):997-1003. PubMed ID: 11685222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo.
    McKinney EC; Streilein JW
    J Immunol; 1989 Sep; 143(5):1560-4. PubMed ID: 2788187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
    Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
    J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral strategies of interference with MHC functions].
    Ishido S; Goto E; Sato Y; Hotta H
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
    [No Abstract]   [Full Text] [Related]  

  • 18. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.